Pharmacy Benefit Consultants - rebates

Pharmacy Middlemen Sue To Stop Rebate Transparency

22 Aug, 2021

By Marty Schladen, August 20, 2021

CVS Boasts That A New Pricing Model Will Lower Drug Costs For Health Plans. Will It?

05 Dec, 2018

By Ed Silverman. December 5, 2018.

What Rebates? Express Scripts Touts A New Plan To Appease Critics Of The Opaque Drug-Pricing System

13 Nov, 2018

By Ed Silverman. November 13, 2018.

Never Mind the Rebates. Maybe Behind-the-Scenes Fees Are Boosting Drug Prices

16 Aug, 2018

By Ed Silverman. August 16, 2018.

It’s Time To Determine How Much Your PBM Is Depriving Your Plan Of Rebates: File An “Accounting” Procedure

10 Jul, 2017

As newspaper articles multiply describing PBMs' questionable rebate conduct, every Plan administrator and fiduciary should consider filing a lawsuit against your PBM seeking an "accounting". As a Plan administrator or fiduciary, you're charged with ensuring your Plan receives

Express Scripts’ Lawsuit Reveals Striking Information About PBM Rebates

31 May, 2017

For years, every PBM has refused to disclose the "rebates" that it earns on a drug-by-drug basis. As a result, no one has been able to detect the "net cost"

Express Scripts Lawsuit Should Raise Everyone’s Eyebrows

31 May, 2017

For years, every PBM has refused to disclose the "rebates" that it earns on a drug-by-drug basis. As a result, no one has been able to detect the "net cost"

Want To Decrease Your Rx Coverage Costs? Pay Attention to Horizon Pharma’s 1st Quarter Report

15 May, 2017

Horizon Pharma - the manufacturer of three extremely expensive drugs - Vimovo, Duexis and Pennsaid – just released its Quarterly Earnings Report causing its stock to plummet. The Report should

Lessons from Horizon Pharma: Stop Covering Vimovo, Duexis and Pennsaid and Stop Relying on Your PBM’s “Standard” Formulary

15 May, 2017

Horizon Pharma - the manufacturer of three extremely expensive drugs - Vimovo, Duexis and Pennsaid – just released its Quarterly Earnings Report causing its stock to plummet. The Report should also

Message from Mylan: It’s Time For Every Health Plan To Address Rebate Issues

17 Nov, 2016

For more than a decade, our firm has called on every PBM to identify all rebates (and other monies) the PBM is receiving from manufacturers - as well as the "net costs" of every drug

In the News